Advertisement
Amazon
Amazon

The Scientist

» innovation and disease/medicine

Most Recent

image: Lasker Winners Announced

Lasker Winners Announced

By | September 10, 2012

This year’s prizes are awarded for advances in liver transplantation, cell biology, and leadership in biomedical science.

0 Comments

image: Fears over Fast-Tracking Drugs

Fears over Fast-Tracking Drugs

By | September 10, 2012

Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.

0 Comments

image: Robot Legs Obey Brain

Robot Legs Obey Brain

By | September 7, 2012

A pair of mechanical leg braces that are controlled by their wearer’s brain signals could help paralyzed patients walk again.

1 Comment

image: Pleasant to the Touch

Pleasant to the Touch

By | September 1, 2012

Scientists hope an understanding of nerve fibers responsive only to gentle touch will give insight into the role the sense plays in social bonding.

0 Comments

image: Opinion: Younger Is Better

Opinion: Younger Is Better

By | August 31, 2012

Stem cells collected from younger donors are more effective for transplantation and regenerative medicine than those from older individuals.

9 Comments

image: Dieting Monkeys Don't Live Longer

Dieting Monkeys Don't Live Longer

By | August 29, 2012

The latest news from a long-term study of calorie restriction in rhesus macaques shows better health, but no boost in lifespan, in monkeys who eat less.

11 Comments

image: Submit Your Innovations Today!

Submit Your Innovations Today!

By | August 29, 2012

You have until the end of this week (Sept. 21 @ 11:59 PM, EDT) to submit your product to The Scientist's 2012 Top 10 Innovations. Be sure to enter your innovative products!

0 Comments

image: Epigenetic Drug Improves Cholesterol Levels

Epigenetic Drug Improves Cholesterol Levels

By | August 28, 2012

Results from a Phase II trial for cardiovascular disease with an epigenetic target therapy show promise.

1 Comment

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

image: Second Victim of Hantavirus

Second Victim of Hantavirus

By | August 28, 2012

Another person has died from the rodent-borne disease after visiting Yosemite National Park.

0 Comments

Advertisement
QIAGEN ingenuity
QIAGEN ingenuity

Popular Now

  1. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  2. A Scrambled Mess
    Features A Scrambled Mess

    Why do so many human eggs have the wrong number of chromosomes?

  3. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

  4. Bacterium Blocks Zika’s Spread
Advertisement
R&D Systems
R&D Systems
Advertisement
RayBioTech